L'atomoxétine (Strattera®), une alternative thérapeutique dans le trouble déficit de l'attention/hyperactivité de l'enfant (TDAH)

Results from clinical trials demonstrated that atomoxetine is effective and well tolerated for the acute and long-term treatment of children and adolescents suffering from ADHD. Atomoxetine should be considered as a new interesting pharmacological option in the treatment of ADHD in association with non pharmacological therapeutic interventions.